Hepatitis, Viral, Human
Recent clinical, regulatory, research and industry developments relating to this disease.
Global burden of liver disease: 2023 update.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes5
- Carcinoma, Hepatocellular1
- Hepatitis, Viral, Human1
- Liver Diseases, Alcoholic1
- Liver Neoplasms1
- Non-alcoholic Fatty Liver Disease1
Leading journals1
- Journal of hepatology1
Leading researchers6
- Arab JP1
- Asrani SK1
- Devarbhavi H1
- Kamath PS1
- Nartey YA1
- Pose E1
Affiliations (unnormalised)6
- Baylor University Medical Center1
- Hospital Clinic of Barcelona1
- Mayo Clinic College of Medicine and Science1
- School of Medical Sciences1
- Schulich School of Medicine1
- St. John's Medical College Hospital1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Reference
Authoritative identity, definition & identifiers.
INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.